bioRxivEvolutionary BiologyPreprint
More efficacious drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
Alison F FederiD, Soo-Yon Rhee, Robert W Shafer, Dmitri A Petrov, Pleuni S Pennings
Abstract
In the early days of HIV treatment, drug resistance occurred rapidly and predictably in all patients, but under modern treatments, resistance arises slowly, if at all. The probability of resistance should be controlled by the rate of generation of resistant mutations. If many adaptive mutations arise simultaneously, then adaptation proceeds by soft selective sweeps in which multiple adaptive mutations spread concomitantly, but if adaptive mutations occur rarely in the population, then a single adaptive mutation should spread alone in a hard selective sweep. Here we use 6,717 HIV-1 consensus sequences from patients treated with first-line therapies between 1989 and 2013 to confirm that the transition from fast to slow evolution of drug resistance was indeed accompanied with the expected transition from soft to hard selective sweeps. This suggests more generally that evolution proceeds via hard sweeps if resistance is unlikely and via soft sweeps if it is likely.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Drug resistance evolution in HIV in the late 1990s: hard sweeps, soft sweeps, clonal interference and the accumulation of drug resistance mutations
K.-A. Williams, P. S. Pennings·bioRxiv·Feb 13, 2019
- The clarifying role of time series data in the population genetics of HIV
A. F. Feder, P. S. Pennings, D. A. Petrov·bioRxiv·Dec 29, 2018
- Haplotype and diversity signatures of ultra-soft selective sweeps in HIV-1
Elena V. Romero, Dylan A Clark, … Alison F. Feder·bioRxiv·Jul 22, 2026
- Kinetic co-evolutionary models predict the temporal emergence of HIV resistance mutations under drug selection pressure
A. Biswas, I. Choudhuri, … R. Levy·bioRxiv·Nov 30, 2022
- Comprehensive Mapping of the Virus and Host Factors that Guide the Paths of HIV-1 Escape from a Therapeutic
Aaron Nicholas Gillman, Cassian M Birler, … Hillel Haim·Cell ReportsPeer-reviewed·Jun 19, 2026
- Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity
A. F. Feder, K. N. Harper, … P. S. Pennings·bioRxiv·Jul 19, 2021